bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.04.11.648347

Genome-wide differentiation and SNP-based identification of northeastern Atlantic Sebastes species

Jansson, E.·Besnier, F.·Christiansen, H.·Saha, A.·Tranang, C. A.·Bruvold, I. M.·Mateos Rivera, A.·Johansen, T.
View original source ↗Export metadata ↓

Abstract

Sustainable fisheries require reliable species identification and understanding of the underlying genetic hierarchies within the targeted species. Three Sebastes species are commonly found in the northeastern Atlantic: Sebastes mentella (beaked redfish), Sebastes norvegicus (golden redfish), and Sebastes viviparus (Norway redfish). These species are morphologically similar and have largely overlapping distribution ranges. Besides, three cryptic species for S. norvegicus and three depth-defined ecotypes for S. mentella have been suggested. Genetic knowledge and methods are needed to identify and monitor these species and to look at their geographic distribution. Here, a total of 99 specimens of S. mentella, S. viviparus as well as S. norvegicus A and B were sequenced in pools and aligned against a reference genome from a sister species, S. fasciatus (Acadian redfish). The measured divergence between all pairs, including the cryptic species pair S. norvegicus A and B, was high (mean FST = 0.33-0.61) and encompassing throughout genomes. Several shared megabase-scale regions of elevated divergence were observed, likely representing regions of reduced recombination. Moreover, 2914 fish collected across the northeastern Atlantic were analysed with a discriminatory SNP panel of high resolution (mean FST= 0.60-0.91), revealed few possible hybrids, and supported further sub-structuring within mentella and S. norvegicus B. The latter was split into two groups, one of which was the previously recognized giant morph and confirmed here for the first time in Norway. Sebastes mentella had two to three groups, likely representing previously identified depth-related ecotypes. Our study shows high genetic distinctiveness between acknowledged northeast-Atlantic Sebastes species, and between the cryptic species S. norvegicus A and B. Previously identified, fast-growing giant seems to be closely related to S. norvegicus B. Only few SNP markers are necessary for accurate species determination, facilitating further studies and widely applicable monitoring.

Explore related subjects

geneticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jansson, E., Besnier, F., Christiansen, H., Saha, A., Tranang, C. A., Bruvold, I. M., Mateos Rivera, A., Johansen, T.. 2025-04-17. Genome-wide differentiation and SNP-based identification of northeastern Atlantic Sebastes species. https://doi.org/10.1101/2025.04.11.648347

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗
bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗
bioRxiv2026

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗